MENAT Syringe Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Syringe Type (Luer Lock Syringes, Glass Syringes, Luer Slip Syringes, and Others), Application (Aesthetics, Human Health, Lab / Industrial, and Others), Usability (Sterilizab

MENAT Syringe Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Syringe Type (Luer Lock Syringes, Glass Syringes, Luer Slip Syringes, and Others), Application (Aesthetics, Human Health, Lab / Industrial, and Others), Usability (Sterilizable/Reusable Syringes and Disposable Syringes), and End User (Hospitals & Clinics, Blood Collection Centers, Diabetic Care Centers, and Others)    

The MENAT syringe market is expected to grow from US$ 882.66 million in 2021 to US$ 1,570.79 million by 2028; it is anticipated to register a CAGR of 8.6% from 2022 to 2028. The market growth is mainly attributed to factors such as growing prevalence of chronic diseases and infectious diseases and increasing adoption of injectable drugs. However, an increase in cases of needlestick or sharp injuries (NSIs) is likely to hinder the market growth.

The MENAT syringe market is segmented into Saudi Arabia, South Africa, the UAE, Turkey, Egypt, Morocco, and the Rest of MENAT. Saudi Arabia and South Africa are expected to be the major contributors to the MENAT syringe market due to the rising prevalence of noncommunicable and communicable diseases.

Increasing Adoption of Injectable Drugs

Parenteral injection offers drug dosage reliability and precision, as well as rapid onset of drug action. Injectable drug delivery devices, such as conventional syringes, needle-free injectors, and auto and pen injectors, are extensively used for drug administration to treat diseases ranging from cancer to autoimmune disorders. The administration of biologics is mainly done through the injectable route. Pharmaceutical companies have started the production of biologics in the MENAT region. For instance, in November 2021, Merck KGaA announced that it would help SaudiVax of Saudi Arabia design and build a multimodality biologics manufacturing facility as part of the country’s efforts to provide a more localized production infrastructure for the Middle East and North Africa region. Further, in December 2020, SaudiVax Ltd. signed a memorandum of understanding (MoU) with Johnson & Johnson Middle East FZ LLC for localization of the manufacturing of top biological drugs. Thus, SaudiVax is established as the manufacturing partner of Johnson & Johnson in Saudi Arabia for local production of drug products of the highest quality.

There is a growing demand for vaccines, insulin, human growth hormone, and many modern medicines to treat cancer and other chronic diseases. As per BioPharm International, biologics currently account for ~70% of the top-10 selling drugs in the world. Thus, the rising adoption of injectable drugs demands increased use of syringes, which is boosting the market growth.

Syringe Type-Based Insights

Based on syringe type, the MENAT syringe market is segmented into luer lock syringes, glass syringes, luer slip syringes, and others. In 2021, the luer lock syringes segment held the largest share of the market. The glass syringes segment is expected to grow fastest in the coming years.

Application-Based Insights

Based on application, the MENAT syringe market is segmented into aesthetics, human health, lab/industrial, and others. In 2021, the human health segment held the largest share of the market. The aesthetics segment is expected to grow at the fastest rate in the coming years.

Usability-Based Insights

Based on usability, the MENAT syringe market is segmented into sterilizable/reusable syringes and disposable syringes. In 2021, the disposable syringes segment held a larger share of the market. The sterilizable/reusable syringes segment is expected to grow at a faster rate during the coming years.

End User-Based Insights

Based on end user, the MENAT syringe market is segmented into hospitals & clinics, blood collection centers, diabetic care centers, and others. In 2021, the hospitals & clinics segment held the largest share of the market. The diabetic care centers segment is expected to grow at the fastest rate in the coming years.

World Health Organization (WHO), US Department of Health and Human Services, Arthritis Foundation, World Heart Federation, American Diabetes Association, Department of Health – Abu Dhabi, International Diabetes Federation (IDF), and National Library of Medicine (NLM) are among the major primary and secondary sources referred to while preparing the report on the MENAT syringe market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the MENAT syringe market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the MENAT syringe market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.